ARS Pharmaceuticals, Inc. SPRY Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s prepaid & other current?
- ARS Pharmaceuticals, Inc. (SPRY) reported prepaid & other current of $6.79M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s prepaid & other current changed year-over-year?
- ARS Pharmaceuticals, Inc.'s prepaid & other current decreased by 41.3% year-over-year, from $11.56M to $6.79M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s prepaid & other current?
- Over 4 years (2021 to 2025), ARS Pharmaceuticals, Inc.'s prepaid & other current has grown at a 25.3% compound annual growth rate (CAGR), from $12.84M to $31.62M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.